Bruker Corp.
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.
Is J&J in the hunt for Boston Scientific? | Acquisitions Roundup
Could the amicable deal between bitter rivals Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) over Michael Mahoney leaving J&J to helm BSX signal an upcoming acquisition?
Opinions are divided on Wall Street, with at least one analyst wondering if a deal could be in the works and others casting doubt on the speculation.
Bruker Announces Agreement to Acquire CETR
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation today announced the signing of a purchase agreement
to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.
CETR, a privately held corporation located in Silicon Valley in
Campbell, CA, is projected to have calendar year 2011 revenue greater
than $10 million and EBITDA greater than $2 million. The transaction is
expected to close at the end of the third quarter of 2011, subject to
customary closing conditions. After the closing, Bruker intends to
continue to operate CETR in Silicon Valley and to integrate its business
management, operations, research and development, sales and support with
MIT’s Langer wins Alpert Prize | Personnel Moves
Bob Langer, MIT professor and bioengineering hot-shot, was chosen to recieve the 2011 Alpert Prize for his advancements in drug delivery and tissue engineering.
Bruker appoints Knight as new CFO
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation (NASDAQ: BRKR) today announced that William J. (‘Bill’) Knight will step back into the Chief Financial Officer role permanently, effective today. Bill Knight will also continue to serve as interim Chief Operating Officer while the company searches for senior operational executives for the areas of manufacturing engineering, production, logistics and global supply chain management in support of Bruker’s continued Operational Excellence initiat
Chinese bribery investigation brings down Bruker’s shares
Bruker Corp.’s (NSDQ:BRKR) investigations of anonymous tips alleging that its Chinese Bruker Optics subsidiary was engaged in bribery turned up evidence of improper payments.
"To date, the investigation has found evidence indicating that payments were made that improperly benefit employees or agents of government-owned enterprises in China," according to SEC filings.
Neoprobe snags another Alseres exec
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
Private equity firms swap Sterigenics for $675 million | Acquisitions roundup
Sterigenics International Inc. is changing private equity ownership for $675 million.
Chicago-based firm GTCR LLC entered into a deal to buy the sterilization and ionization services company from fellow Chicagoans PPM America Capital Partners and Europe-based Silverfleet Capital.
The companies expect the deal to close by the end of the second quarter of 2011.
Bruker breaks annual sales record in spite of lower Q4 profits | Earnings roundup
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Bruker, BD partner up on microbe tests
Bruker Corp. (NSDQ:BRKR) subsidiary Bruker Daltonics Inc. signed a co-development and co-marketing deal with Franklin Lakes, N.J.-based Becton, Dickinson & Co. (NYSE:BDX) BD Diagnostics division.
